BetaEntity Annotation Prototype
← Back to funders

Annotated abstract

Limit use of nasal decongestant sprays to five days, UK regulator says

bmj · 2026-05-01 · canonical JSON source

4 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

New advice to limit the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days has been issued by the UK’s drug regulator.